Ignite Creation Date:
2024-05-05 @ 11:32 PM
Last Modification Date:
2024-10-26 @ 10:35 AM
Study NCT ID:
NCT01356875
Status:
UNKNOWN
Last Update Posted:
2011-05-20
First Post:
2011-05-18
Brief Title:
Treatment of Myelodysplastic Syndromes Comparing HydralazineAc Valproic and Supportive Care in Patients Not Candidates Refractory andor Intolerant to Intensive Chemotherapy
Sponsor:
Basque Health Service
Organization:
Basque Health Service